Azalea Life Sciences Private Limited
About Azalea Life Sciences Private Limited
Data last updated:
Azalea Life Sciences Private Limited is a private limited company based in Sarkhej, Gujarat, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U51909GJ2017PTC097257. Its GSTIN is 24AAPCA5520R1Z7 (Gujarat).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Malay Chandrakantbhai Mehta and Hiteshkumar Ratilal Chauhan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 23 Meghraji Complex B/H.Navjivan Hotel, Sarkhej, Gujarat, India – 380007.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.34 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹91,510 (net margin 68.4%) and EBITDA of ₹79,161 (EBITDA margin 59.2%). Revenue has declined at a compounded annual rate (CAGR) of 59% over three years and 74% over five years.
As per MCA filings, the company has open charges of ₹1 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Azalea Life Sciences Private Limited's registered office is in Sarkhej, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address23 Meghraji Complex B/H.Navjivan Hotel, Sarkhej, Gujarat, India – 380007
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Azalea Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Azalea Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Azalea Life Sciences Private Limited
FY 2025 filings availableAzalea Life Sciences Private Limited reported revenue of ₹1.34 Lakh (up 43% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 43% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 74%. EBITDA rose 162% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹79,161 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹91,510 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 59.2% | ||||
| Net Profit Margin | 68.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Azalea Life Sciences Private Limited, buy the company report.
Board of directors of Azalea Life Sciences Private Limited
Azalea Life Sciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Malay Chandrakantbhai Mehta | Director | 10 May 2017 | 9 Years 5 Months | Current |
| Hiteshkumar Ratilal Chauhan Also directs: Floris Biotech LLP, Aquaren Pharmaceuticals Private Limited, Eutrophic Pharmaceuticals Private Limited and 1 more | Director | 10 May 2017 | 9 Years 5 Months | Current |
Peer comparison
Azalea Life Sciences Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Azymus Lifesciences Private Limited | ₹1.38 Lakh (FY 2024) | -66.0% | Chamarajanagar, Karnataka, India | |||
| Abiezer Pharma Private Limited | ₹1.37 Lakh (FY 2025) | 38.0% | Delhi, India | |||
| Adore Meditech Private Limited | ₹1.37 Lakh (FY 2025) | 10.0% | Chandigarh, India | |||
| Buddy's Medicare Private Limited | ₹1.36 Lakh (FY 2025) | 46.0% | Bhubaneswar, Odisha, India | |||
| Azalea Life Sciences Private Limitedthis company | ₹1.34 Lakh (FY 2025) | ₹91,510 | 68.4% | 43.0% | Sarkhej, Gujarat, India | |
| Nexon Surgicals Private Limited | ₹1.32 Lakh (FY 2024) | -14.0% | Bhubaneswar, Odisha, India | |||
| Adoshine Pharmaceuticals Private Limited | ₹1.32 Lakh (FY 2025) | 777.0% | New Delhi, Delhi, India | |||
| Nesika Life Sciences Private Limited | ₹1.31 Lakh (FY 2022) | Guwahati, Assam, India | ||||
| Necs Pharma Private Limited | ₹1.31 Lakh (FY 2016) | Navi Mumbai, Maharashtra, India |
To see the full peer comparison of Azalea Life Sciences Private Limited, buy the company report.
Auditor
Azalea Life Sciences Private Limited is audited by V K JINDAL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V K JINDAL & CO | FY 2021 | 001468C |
Shareholding
The shareholding of Azalea Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Azalea Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Feb 2019 | 100245399 | Others | ₹50 Lakh | Open | |
| 12 Feb 2019 | 100245910 | Others | ₹50 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Azalea Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Azalea Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Azalea Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAPCA5520R1Z7 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Azalea Life Sciences Private Limited, buy the company report.
Recent activity
Azalea Life Sciences Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Hiteshkumar Ratilal Chauhan was appointed as Director on 10 May 2017.
Frequently asked questions
Azalea Life Sciences is an active private limited company based in Sarkhej, Gujarat, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 May 2017 (9+ years old) and is registered under CIN U51909GJ2017PTC097257.
Azalea Life Sciences has 2 current directors:
- Malay Chandrakantbhai Mehta - Director
- Hiteshkumar Ratilal Chauhan - Director
The latest financial statements of Azalea Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Azalea Life Sciences is 24AAPCA5520R1Z7, registered in Gujarat.
The CIN (Corporate Identification Number) of Azalea Life Sciences is U51909GJ2017PTC097257. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Azalea Life Sciences was incorporated on 10 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Azalea Life Sciences by revenue are Azymus Lifesciences Private Limited, Abiezer Pharma Private Limited, Adore Meditech Private Limited, Buddy's Medicare Private Limited, Nexon Surgicals Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Hiteshkumar Ratilal Chauhan was appointed as Director on 10 May 2017. Malay Chandrakantbhai Mehta was appointed as Director on 10 May 2017.
The registered office of Azalea Life Sciences is at 23 Meghraji Complex BH.Navjivan Hotel, Sarkhej, Gujarat, India – 380007.
Azalea Life Sciences operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Azalea Life Sciences has open charges of ₹1 Cr and no satisfied charges on record as per latest MCA filings.